The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer

The long-term outcomes following surgical resection for pancreatic ductal adenocarcinoma (PDAC) remains poor, with only 20% of patients surviving 5 years after pancreatectomy. Patient selection for surgery remains suboptimal largely due to the absence of consideration of aggressive tumor biology. OB...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreyer, Stephan B., Rae, Sarah, Bisset, Kirsty, Upstill-Goddard, Rosie, Gemenetzis, Georgios, Johns, Amber L., Dickson, Euan J., Mittal, Anubhav, Gill, Anthony J., Duthie, Fraser, Pea, Antonio, Lawlor, Rita T., Scarpa, Aldo, Salvia, Roberto, Pulvirenti, Alessandra, Zerbi, Alessandro, Marchesi, Federica, McKay, Colin J., Biankin, Andrew V., Samra, Jaswinder S., Chang, David K., Jamieson, Nigel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831035/
https://www.ncbi.nlm.nih.gov/pubmed/36745763
http://dx.doi.org/10.1097/SLA.0000000000005050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831035/
https://www.ncbi.nlm.nih.gov/pubmed/36745763
http://dx.doi.org/10.1097/SLA.0000000000005050

Ejemplares similares